Archives
-
How Near-Death Tumor Cells Become Metastatic
2026-09-04
Conod, Silvano, and Ruiz i Altaba propose that impending cell death can actively induce stable prometastatic states rather than merely select pre-existing aggressive cells. Their study links ER stress, PERK-CHOP signaling, GLI and NANOG-dependent reprogramming, and cytokine-mediated communication to the formation of PAMEs and PIMs, providing a framework for studying metastasis prevention after cytotoxic stress.
-
AY 9944 dihydrochloride: DHCR7 Workflow
2026-09-04
Use AY 9944 dihydrochloride as a reversible way to shift sterol balance, connect 7-dehydrocholesterol accumulation with membrane or immune phenotypes, and benchmark DHCR7-dependent biology. This guide translates biochemical, PBMC, membrane-raft, and emerging antiviral evidence into practical assay decisions while separating chemical inhibition from gene knockout.
-
Glycogen Colorimetric Assay Kit II Workflow
2026-09-03
Build a practical glycogen measurement workflow for liver, muscle, and cell samples where reducing substances can complicate oxidase-based assays. The Glycogen Colorimetric Assay Kit II combines enzymatic hydrolysis, glucose oxidation, and 450 nm detection for circadian exercise studies, metabolic phenotyping, and glycogen storage disease research.
-
CBD, CB1/CB2 Signaling, and Orofacial Pain
2026-09-03
This 2026 mouse study shows that cannabidiol (CBD) can reduce both inflammatory orofacial nociception and pain-associated affective and cognitive deficits. Its central contribution is the separation of peripheral CB2-linked anti-inflammatory effects from central CB1- and serotonin-related modulation of pain processing and emotional behavior.
-
From CD38 CAR Design to Actionable Apoptosis Data
2026-09-02
Structural tuning of CD38 CAR binders is only translationally valuable when it produces measurable gains in selectivity, cytotoxicity, and cellular fitness. This article shows how Annexin V-PE Reagent can connect binder geometry with early phosphatidylserine exposure, target-cell killing, and CAR-T fratricide in a practical development workflow.
-
BH3 Mimetics in TP53-Wild-Type Breast Cancer
2026-09-02
Shahbandi and colleagues show that chemotherapy-induced senescent breast cancer cells can remain dependent on anti-apoptotic BCL-XL or combined BCL-XL/MCL1 signaling. Their study links post-chemotherapy senolysis with greater tumor regression and survival in TP53 wild-type models, while identifying NOXA expression and apoptotic dependency as important determinants of response.
-
SB 431542: Practical ALK5 Inhibitor Workflows
2026-09-01
SB 431542 gives researchers a selective way to interrogate ALK5-dependent TGF-β signaling, from Smad2 phosphorylation assays to epithelial tissue-engineering workflows. Its value is greatest when paired with target-engagement controls, pathway-specific rescue logic, and careful interpretation of ALK4/ALK7 activity.
-
Preeclampsia UCMSCs: Senescence and Cytoskeletal Dysfunction
2026-09-01
The reference study shows that umbilical cord mesenchymal stem cells from preeclampsia pregnancies have reduced proliferative capacity alongside senescence-associated, mitochondrial, and cytoskeletal abnormalities, despite broadly preserved stem-cell characterization. Its combined transcriptomic, imaging, and functional approach identifies cellular senescence and cytoskeletal instability as experimentally testable targets, with dasatinib plus quercetin partially improving the phenotype in vitro.
-
Trichostatin A (TSA): Practical Lab Guide
2026-08-31
This guide explains how to prepare, control, and interpret Trichostatin A (TSA, SKU A8183) in cell-based HDAC, epigenetic, and cancer research workflows. It is intended for exploratory laboratory studies rather than clinical use, and the listed assay conditions should not be treated as universal doses or validated therapeutic protocols.
-
Caveolin-1 Restores Cholesterol Balance in MASLD
2026-08-31
A 2025 study links declining hepatic caveolin-1 (CAV1) to cholesterol accumulation, endoplasmic reticulum stress, and pyroptosis during metabolic dysfunction-associated steatotic liver disease (MASLD). By combining CAV1-deficient mice, liver transcriptomics, human samples, and in vitro assays, the authors identify an FXR/NR1H4–ABCG5/ABCG8 pathway that connects cholesterol homeostasis with inflammatory liver injury.
-
α-Amanitin: RNA Polymerase II Inhibitor
2026-08-30
α-Amanitin is a potent RNA polymerase II inhibitor that blocks transcription elongation and mRNA synthesis. Its strongest experimental use is as a controlled perturbation for transcriptional regulation research, while its hepatotoxicity requires strict research-only handling and model-specific interpretation.
-
Nelfinavir Mesylate in Cell Assays
2026-08-29
Learn how Nelfinavir Mesylate (SKU A3653) can improve interpretation and reproducibility in HIV, viability, proliferation, and ferroptosis experiments. This scenario-based guide connects quantitative product data with practical solvent, dosing, controls, and vendor-selection decisions.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-08-28
Cy5 NHS ester(Et) is an amine-reactive fluorescent reagent for covalently labeling proteins, peptides, and other biomolecules in fluorescence workflows. It is suited to freshly prepared aqueous or DMSO-assisted labeling, but ethanol-based protocols and long-term storage of prepared solutions should be avoided.
-
Benzyl-activated Streptavidin Magnetic Beads
2026-08-28
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) support magnetic capture of biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from complex samples. They are suited to purification, immunoprecipitation, interaction assays, and screening workflows, but require caution for covalent-capture designs, live-cell applications, and downstream assays sensitive to BSA or sodium azide.
-
Trichostatin A for Chromatin and Cell-State Assays
2026-08-27
Trichostatin A (TSA) gives researchers reversible control over histone deacetylation for studying chromatin, proliferation, and differentiation. This guide translates a dynamic cardiomyocyte chromatin map into practical TSA perturbation workflows while preserving clear boundaries between hypothesis generation and causal evidence.